Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel), confirmed by a CT or MRI brain scan
- People whose stroke started within the last 30 days
- People who have evidence of a build-up of fatty deposits (atherosclerosis) in at least one artery — such as in the neck, heart, main body artery, kidneys, or legs — detected through a scan or ultrasound
- People who have given their written agreement to take part in the trial
Who may not be able to join:
- People with a known allergy to Probucol or statin medications
- People whose artery narrowing is caused by something other than fatty deposit build-up, such as blood vessel inflammation, moyamoya disease, or a torn artery wall
- People who have a heart condition that may cause blood clots to travel to the brain, such as an irregular heartbeat (atrial fibrillation), artificial heart valves, heart valve infection, or a hole between the heart's upper chambers
- People with a known tendency to bleed or a bleeding disorder, including a low platelet count, a previous bleeding stroke, or recent stomach or bowel bleeding
- People with serious heart muscle disease, such as a recent heart attack or heart muscle inflammation
- People with significant liver or kidney problems, based on specific blood test results (confirm with trial site)
- People with certain heart rhythm problems, including fast or slow heartbeat abnormalities, a specific irregular rhythm called torsades de pointes, or fainting episodes linked to the heart
- People with a prolonged QT interval (an abnormality in the heart's electrical activity) or conditions or medications that may cause this
- People with a serious illness where life expectancy is less than one year, or people who are unable to participate due to cognitive or psychological difficulties
- People who have taken Probucol or certain cholesterol-lowering medications (other than statins, ezetimibe, or PCSK9 inhibitors) in the 30 days before joining the trial
- People who are pregnant, breastfeeding, or trying to become pregnant
- People who are currently taking part in another clinical trial involving an experimental drug or device, or who have done so in the past 30 days
- People who have planned surgery or a procedure that would require stopping the trial medication during the study
- People for whom the trial team has identified a reason that participation or follow-up may not be possible
- People excluded for other medical reasons as determined by the trial investigator (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jing Dong, Doctor, Xuanwu Hospital, Beijing
Phone: +86 13501390691
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Plaque Burden from Baseline to 12-Month Follow-up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.